More articles from COPD

Subjective swallowing symptoms and related risk factors in COPD
Margareta Gonzalez Lindh, Andrei Malinovschi, Eva Brandén, Christer Janson, Björn Ställberg, Kristina Bröms, Monica Blom Johansson, Karin Lisspers, Hirsh Koyi

ERJ Open Research Jul 2019, 5 (3) 00081-2019; DOI: 10.1183/23120541.00081-2019
Treatment decisions in end-stage COPD: who decides how? A cross-sectional survey of different medical specialties
Martin Gäbler, Gerald Ohrenberger, Georg-Christian Funk

ERJ Open Research Jul 2019, 5 (3) 00163-2018; DOI: 10.1183/23120541.00163-2018
Improvements in functional and cognitive status following short-term pulmonary rehabilitation in COPD lung transplant recipients: a pilot study
Vasileios Andrianopoulos, Rainer Gloeckl, Martina Boensch, Katharina Hoster, Tessa Schneeberger, Inga Jarosch, Rembert A. Koczulla, Klaus Kenn

ERJ Open Research Jul 2019, 5 (3) 00060-2019; DOI: 10.1183/23120541.00060-2019
Using wearables and self-management apps in patients with COPD: a qualitative study
Robert C. Wu, Shiphra Ginsburg, Tatiana Son, Andrea S. Gershon

ERJ Open Research Jul 2019, 5 (3) 00036-2019; DOI: 10.1183/23120541.00036-2019
Comparative effectiveness of triple therapy versus dual bronchodilation in COPD
Jaco Voorham, Massimo Corradi, Alberto Papi, Claus F. Vogelmeier, Dave Singh, Leonardo M. Fabbri, Marjan Kerkhof, Janwillem H. Kocks, Victoria Carter, David Price

ERJ Open Research Jul 2019, 5 (3) 00106-2019; DOI: 10.1183/23120541.00106-2019
A specific proteinase 3 activity footprint in α₁-antitrypsin deficiency
Paul R. Newby, Diana Crossley, Helena Crisford, James A. Stockley, Richard A. Mumford, Richard I. Carter, Charlotte E. Bolton, Nicholas S. Hopkinson, Ravi Mahadeva, Michael C. Steiner, Tom M.A. Wilkinson, Elizabeth Sapey, Robert A. Stockley

ERJ Open Research Jul 2019, 5 (3) 00095-2019; DOI: 10.1183/23120541.00095-2019
Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial
Vijay Kunadian, Nina Wilson, Deborah D. Stocken, Hani Ali, Elaine McColl, Graham Burns, Nicola Howe, Andrew Fisher, Anthony De Soyza

ERJ Open Research Jul 2019, 5 (3) 00110-2019; DOI: 10.1183/23120541.00110-2019
Validity of the diagnosis of pneumonia in hospitalised patients with COPD
Lydia J. Finney, Vijay Padmanaban, Samuel Todd, Nadia Ahmed, Sarah L. Elkin, Patrick Mallia

ERJ Open Research Apr 2019, 5 (2) 00031-2019; DOI: 10.1183/23120541.00031-2019
Memory, attention and fluency deficits in COPD may be a specific form of cognitive impairment
Charlotte Morris, James W. Mitchell, Hannah Moorey, Helen-Cara Younan, George Tadros, Alice M. Turner

ERJ Open Research Apr 2019, 5 (2) 00229-2018; DOI: 10.1183/23120541.00229-2018
Exploring the potential benefits of digital health technology for the management of COPD: a qualitative study of patient perceptions
Patrick Slevin, Threase Kessie, John Cullen, Marcus W. Butler, Seamas C. Donnelly, Brian Caulfield

ERJ Open Research Apr 2019, 5 (2) 00239-2018; DOI: 10.1183/23120541.00239-2018

Main menu

User menu

Search

More articles from COPD

Pages

Contact us